SXTP סך כל יתרות המזומנים של החברה 60degreespharma.com

סמל מסחרי של 60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals (SXTP) delegates drug manufacturing and testing to external contractors to optimize global delivery. Analyzing the chart on GURU.Markets, we see that the cash balance has reached a level where 0.00 determines this parameter. This supports the orphan infection therapy ecosystem with a protected patent for Aravacon. The lack of modern alternatives for malaria treatment provides the issuer with significant pricing power.

60 Degrees Pharmaceuticals - יתרת המזומנים של החברה SXTP (תקופה 21.02.2024 - 21.11.2026)

פילוחי נתונים אנליטיים מרוכזים עבור 60 Degrees Pharmaceuticals (SXTP)

- שווי מניות ותחזית קונצנזוס למחירים:
- נתוני מזומנים ותזרימי מזומנים:
ניתוח ראשוני של החברה:SXTP 60 Degrees Pharmaceuticals
פריט של המותג 60 Degrees Pharma

Developing antimalarial drugs requires stable funding for clinical phases regardless of market cycles. This indicator tracks the daily liquid asset balance, accounting for every inflow and outflow in real time for 60 Degrees Pharmaceuticals (SXTP). Such a metric determines the business's ability to avoid cash flow gaps and promptly meet its obligations. Excess capital ensures macro-stability but may slow the pace of expansion. Analyzing changes in cash asset volume allows for an assessment of the company's current margin of safety.